Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Share News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,439.00
Bid: 1,439.00
Ask: 1,440.00
Change: 6.00 (0.42%)
Spread: 1.00 (0.069%)
Open: 1,425.00
High: 1,448.00
Low: 1,425.00
Prev. Close: 1,433.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BROKER RATINGS: Barclays Cuts Babcock To Underweight From Overweight

Wed, 27th Jan 2021 09:32

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

----------

FTSE 100

----------

BERENBERG RAISES INTERTEK TO 'BUY' ('HOLD') - TARGET 6,450 (5,750) PENCE

----------

BERENBERG CUTS ROLLS-ROYCE PRICE TARGET TO 130 (140) PENCE - 'BUY'

----------

JPMORGAN CUTS ROLLS-ROYCE PRICE TARGET TO 45 (50) PENCE - 'UNDERWEIGHT'

----------

GOLDMAN SACHS CUTS ROLLS-ROYCE PRICE TARGET TO 107 (122) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS ROLLS-ROYCE PRICE TARGET TO 53 (59) PENCE - 'UNDERPERFORM'

----------

BANK OF AMERICA CUTS BAE SYSTEMS PRICE TARGET TO 510 (555) PENCE - 'NEUTRAL'

----------

GOLDMAN SACHS RAISES BARCLAYS PRICE TARGET TO 180 (170) PENCE - 'NEUTRAL'

----------

LIBERUM RAISES INTERNATIONAL CONSOLIDATED AIRLINES PENCE PRICE TARGET TO 150 (100) PENCE - 'HOLD'

----------

BERENBERG RAISES INTERNATIONAL CONSOLIDATED AIRLINES PRICE TARGET TO 190 (180) PENCE - 'BUY'

----------

JPMORGAN CUTS ROYAL DUTCH SHELL B PRICE TARGET TO 1,700 (1,800) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES PEARSON PRICE TARGET TO 769 (742) PENCE - 'BUY'

----------

FTSE 250

----------

BARCLAYS CUTS BABCOCK INTERNATIONAL TO 'UNDERWEIGHT' ('OVERWEIGHT') - TARGET 145 (347) PENCE

----------

GOLDMAN SACHS REINITIATES CENTRICA WITH 'BUY' - PRICE TARGET 67 PENCE

----------

COMMERZBANK CUTS TUI TO 'REDUCE' (HOLD) - PRICE TARGET LOWERED TO 3 EUR

----------

LIBERUM CUTS EASYJET PRICE TARGET TO 1000 (1200) PENCE - 'BUY'

----------

BERENBERG RAISES EASYJET PRICE TARGET TO 850 (820) PENCE - 'HOLD'

----------

BERENBERG RAISES WIZZ AIR PRICE TARGET TO 4,800 (4,200) PENCE - 'BUY'

----------

RBC RAISES BREWIN DOLPHIN HOLDINGS PRICE TARGET TO 385 (375) PENCE - 'OUTPERFORM'

----------

BERENBERG RAISES PETS AT HOME PRICE TARGET TO 500 (480) PENCE - 'BUY'

----------

RBC CUTS BEAZLEY PRICE TARGET TO 410 (415) PENCE - 'OUTPERFORM'

----------

BARCLAYS RAISES QUILTER PRICE TARGET TO 145 (140) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES CREST NICHOLSON PRICE TARGET TO 335 (255) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES CREST NICHOLSON PRICE TARGET TO 330 (280) PENCE - 'HOLD'

----------

JEFFERIES RAISES GREENCORE TO 'BUY' ('HOLD') - TARGET 150 (106) PENCE

----------

CITIGROUP RAISES INDIVIOR PRICE TARGET TO 185 (165) PENCE - 'BUY'

----------

BARCLAYS RAISES UDG HEALTHCARE PRICE TARGET TO 920 (875) PENCE - 'OVERWEIGHT'

----------

BANK OF AMERICA CUTS ULTRA ELECTRONICS PRICE TARGET TO 1,960 (2,000) PENCE - 'UNDERPERFORM'

----------

UBS RAISES COMPUTACENTER PRICE TARGET TO 2,135 (2,030) PENCE - 'SELL'

----------

OTHER MAIN MARKET AND AIM

----------

LIBERUM CUTS RYANAIR PRICE TARGET TO 15 (17) EUR - 'HOLD'

----------

BERENBERG RAISES RYANAIR PRICE TARGET TO 15 (12) EUR - 'HOLD'

----------

JPMORGAN CUTS TULLOW OIL PRICE TARGET TO 26 (27) PENCE - 'NEUTRAL'

----------

BERENBERG RAISES RPS GROUP PRICE TARGET TO 100 (60) PENCE - 'BUY'

----------

RBC RAISES RPS GROUP PRICE TARGET TO 110 (80) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK RAISES FORTERRA PRICE TARGET TO 284 (259) PENCE - 'BUY'

----------

JEFFERIES RAISES FORTERRA PRICE TARGET TO 247 (231) PENCE - 'HOLD'

----------

BERENBERG RAISES GRIFFIN MINING PRICE TARGET TO 170 (130) PENCE - 'BUY'

----------

BARCLAYS RAISES BOOHOO PRICE TARGET TO 510 (425) PENCE - 'OVERWEIGHT'

----------

GOLDMAN SACHS RAISES DAILY MAIL PRICE TARGET TO 681 (680) PENCE - 'SELL'

----------

BANK OF AMERICA RAISES SENIOR PRICE TARGET TO 73 (65) PENCE - 'UNDERPERFORM'

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Jun 2021 17:05

LONDON MARKET CLOSE: Lower finish fails to dent FTSE's strong quarter

LONDON MARKET CLOSE: Lower finish fails to dent FTSE's strong quarter

Read more
30 Jun 2021 13:44

Wednesday broker round-up

(Sharecast News) - Workspace: RBC Capital Markets upgrades to outperform with a target price of 1,050p.

Read more
30 Jun 2021 12:17

LONDON MARKET MIDDAY: Stocks slide ahead of US ADP jobs report

LONDON MARKET MIDDAY: Stocks slide ahead of US ADP jobs report

Read more
30 Jun 2021 10:41

Indivior raises profit and revenue guidance after strong start to year

Indivior raises profit and revenue guidance after strong start to year

Read more
30 Jun 2021 09:02

LONDON MARKET OPEN: Indivior shines after upgrading guidance

LONDON MARKET OPEN: Indivior shines after upgrading guidance

Read more
30 Jun 2021 07:58

LONDON MARKET PRE-OPEN: Dividend contrast from Dixons and Stagecoach

LONDON MARKET PRE-OPEN: Dividend contrast from Dixons and Stagecoach

Read more
30 Jun 2021 07:35

Indivior lifts 2021 guidance after better-than-expected H1

(Sharecast News) - Opioid addiction treatment maker Indivior lifted its 2021 guidance on Wednesday following a better-than-expected business performance through the first half of the year.

Read more
21 Jun 2021 09:34

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

BROKER RATINGS: UBS cuts Rio Tinto to Sell; Morgan Stanley ups Ocado

Read more
8 Jun 2021 14:27

IN BRIEF: Indivior secures license for cannabis disorder treatment

IN BRIEF: Indivior secures license for cannabis disorder treatment

Read more
8 Jun 2021 12:36

Indivior joins forces with France's Aelis on treatment for cannabis use disorder

(Sharecast News) - Indivior said on Tuesday that it has teamed up with French biotechnology group Aelis to advance the clinical development of a treatment for cannabis use disorder.

Read more
8 Jun 2021 12:36

Indivior teams up with Aelis on treatment for cannabis use disorder

(Sharecast News) - Indivior said on Tuesday that it has teamed up with French biotechnology group Aelis to advance the clinical development of a treatment for cannabis use disorder.

Read more
6 May 2021 17:50

UPDATE: Pay comes under spotlight at BAE, Indivior and Rio Tinto AGMs

UPDATE: Pay comes under spotlight at BAE, Indivior and Rio Tinto AGMs

Read more
29 Apr 2021 16:11

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
29 Apr 2021 12:26

Indivior maintains 2021 guidance as first quarter revenue increases

Indivior maintains 2021 guidance as first quarter revenue increases

Read more
28 Apr 2021 10:47

Indivior says US filings "administrative", no new Suboxone settlements

Indivior says US filings "administrative", no new Suboxone settlements

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.